| Date | Form | Description | Docs | XBRL | Pages |
| 01/10/25 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
41 |
| 01/16/24 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
46 |
| 01/04/23 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
40 |
| 01/04/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
63 |
| 01/07/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
77 |
| 01/10/20 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
110 | |
| 01/09/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
128 |
| 01/11/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
95 |
| 01/09/18 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
148 |
| 12/08/16 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
|
85 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...